IL1 receptor antagonist controls transcriptional signature of inflammation in patients with metastatic breast cancer.
Times cited: 15
Reprogramming tumor-infiltrating dendritic cells for CD103+ CD8+ mucosal T-cell differentiation and breast cancer rejection.
Cancer Immunology Research.
Times cited: 33
Human cd1c+ dendritic cells drive the differentiation of cd103+ cd8+ mucosal effector t cells via the cytokine tgf-β.
Times cited: 92